猪用疫苗市场:现状分析与预测(2022-2028年)

由于对猪肉和其他猪肉产品的需求不断增长，以及人们对疫苗接种在动物健康中的重要性的认识不断提高，猪疫苗市场预计将以 5% 左右的速度稳定增长。疫苗技术的进步、政府对动物健康的承诺加大以及新的复杂猪病的出现也推动了市场的发展。

亚洲地区最大的猪疫苗市场是中国，在全球市场中占有很大占有率。该国是全球最大的猪肉生产国，除了猪肉需求不断增长外，非洲猪瘟等猪病疫情的爆发也导致猪疫苗需求激增。例如，2022 年 4 月，美国农业部农业研究服务处 (ARS) 的调查人员宣布，一种非洲猪瘟 (ASF) 候选疫苗已通过监管部门批准所需的关键安全测试，并且该疫苗可以投入商业使用.我们宣布我们离使用它又近了一步。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制事项

第2章 调查手法或前提

• 调查流程
• 调查手法
• 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对猪用疫苗市场带来的影响

第6章 猪用疫苗的市场收益，2020-2028年

第7章 市场洞察:各类型

• 减毒活病毒疫苗
• 不活化疫苗
• 次单元疫苗
• DNA疫苗
• 重组疫苗

第8章 市场洞察:各产品类型

• 猪流感
• 猪瘟热
• 猪微小病毒
• 猪环状病毒2型
• 猪豹
• 其他

第9章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 全球其他地区

第10章 猪用疫苗市场动态

• 推动市场要素
• 市场课题
• 影响分析

第11章 猪用疫苗市场机会

第12章 猪用疫苗市场趋势

第13章 需求面和供给面的分析

• 需求面分析
• 供给面分析

第14章 价值链分析

第15章 价格分析

第16章 策略性洞察能力

第17章 竞争模式

• 竞争情形
  • 波特的五力分析

第18章 企业简介

• Merck & Co., Inc.
• Ceva
• Zoetis
• Boehringer Ingelheim International GmbH
• Elanco
• Indian Immunologicals Ltd.
• Biogenesis Bago
• Phibro Animal Health Corporation
• KM Biologics
• HIPRA, S.A.

第19章 免责声明

Swine vaccines are used to prevent and control a wide range of diseases that affect pigs. These diseases can cause significant economic losses for swine producers, and in some cases, they can also pose a public health risk. Swine vaccines help to prevent and control diseases, reduce the need for antibiotics, and improve the overall health and welfare of pigs. The swine vaccine market is expected to continue to grow due to increasing demand for pork and swine products, advances in vaccine technology, and the emergence of new and complex swine diseases. Vaccination is a key tool in protecting swine health and ensuring food safety, and it will continue to play an important role in the swine industry in the years to come.

The swine vaccines market is expected to grow at a steady rate of around 5% owing to due to increasing demand for pork and other swine products, as well as the growing awareness of the importance of vaccination in animal health. The market is also driven by advances in vaccine technology, increasing government initiatives for animal health, and the emergence of new and complex swine diseases.

Based on product type, the market is segmented into attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines. The inactivated vaccines category is to witness higher CAGR during the forecast period. This is mainly due to the inactivated vaccines are considered to be very safe, as they cannot cause disease in the person being vaccinated, these vaccines are often more stable than live vaccines, more effective at stimulating an immune response, and ability to rapidly respond to emerging diseases are factors contributing to the growing popularity this segment.

On the basis of type, the market is categorized into swine influenza, classical swine fever, porcine parvovirus, porcine circovirus type 2, and m.hyo. Among these, the porcine parvovirus held a significant share in the market in 2021. This is mainly due to the high prevalence of porcine parvovirus in pig herds worldwide, there is a high demand for vaccines to control and prevent its spread. In addition, several major animal health companies manufacture and distribute porcine parvovirus vaccines, which also contributes to its dominance in the market.

For a better understanding of the market adoption of the swine vaccines industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing demand for pork meat, rising prevalence of swine diseases, and government initiatives for livestock disease control. The Asia region, which includes countries such as China, India, Japan, South Korea, and Thailand, is one of the largest producers of pork in the world.

China is the largest market for swine vaccines in the Asia region, accounting for a significant share of the global market. The country is the world's largest pork producer, and the increasing demand for pork meat, along with the growing prevalence of swine diseases such as African swine fever, has led to a surge in demand for swine vaccines. For instance, in April 2022, Scientists with the United States Department of Agriculture's Agricultural Research Service (ARS) announced that a vaccine candidate for African Swine Fever (ASF) passed an important safety test required for regulatory approval, moving the vaccine one step closer to commercial availability.

Some of the major players operating in the market include: Merck & Co., Inc.; Ceva; Zoetis; Boehringer Ingelheim International GmbH; Elanco; Indian Immunologicals Ltd.; Biogenesis Bago; Phibro Animal Health Corporation; KM Biologics; and HIPRA, S.A.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Swine Vaccines Market
• 2.2. Research Methodology of the Swine Vaccines Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SWINE VACCINES MARKET

6 SWINE VACCINES MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

• 7.1. Attenuated Live Vaccines
• 7.2. Inactivated Vaccines
• 7.3. Subunit Vaccines
• 7.4. DNA Vaccines
• 7.5. Recombinant Vaccines

8 MARKET INSIGHTS BY PRODUCT TYPE

• 8.1. Swine Influenza
• 8.2. Classical Swine Fever
• 8.3. Porcine Parvovirus
• 8.4. Porcine Circovirus Type 2
• 8.5. M.Hyo
• 8.6. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 SWINE VACCINES MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 SWINE VACCINES MARKET OPPORTUNITIES

12 SWINE VACCINES MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

• 18.1. Merck & Co., Inc.
• 18.2. Ceva
• 18.3. Zoetis
• 18.4. Boehringer Ingelheim International GmbH
• 18.5. Elanco
• 18.6. Indian Immunologicals Ltd.
• 18.7. Biogenesis Bago
• 18.8. Phibro Animal Health Corporation
• 18.9. KM Biologics
• 18.10. HIPRA, S.A.

19 DISCLAIMER